Ofatumumab for High-Risk Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Clinical trial NCT01243190 · COMPLETED
Trial details
- NCT number
- NCT01243190
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2023-03-28
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.